A Study of RAY1225 in Participants With Type 2 Diabetes Not Controlled With Diet and Exercise Alone

NCT07139535 · clinicaltrials.gov ↗

PHASE3

Phase

NOT_YET_RECRUITING

Status

350

Enrollment

INDUSTRY

Sponsor class

Conditions

T2DM

Interventions

DRUG: RAY1225
DRUG: placebo

Sponsor

Guangdong Raynovent Biotech Co., Ltd